Skip to main content
Equibles
CMPS logo

CMPS · COMPASS Pathways plc · Webcasts, Transcripts & Audio

Track CMPS — free

Use CMPS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CMPS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$11.81 +0.76 (+6.88%) At close · Oct 27 Q2 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$1.53B
Shares
138.48M
Volume · Oct 27 2.27M Avg daily vol (3M) 2.68M

COMPASS Pathways plc Webcasts

Earnings calls, investor updates, investor days and conferences for COMPASS Pathways plc (CMPS), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP → Add these events to your calendar (.ics)
Conference
Investor event
2026-12-01
COMPASS Pathways plc (CMPS) December 1, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-18
COMPASS Pathways plc (CMPS) November 18, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-11-11
COMPASS Pathways plc (CMPS) November 11, 2026 Conference
Scheduled
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q3
2026-11-03
COMPASS Pathways plc (CMPS) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-16
COMPASS Pathways plc (CMPS) September 16, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-09-15
COMPASS Pathways plc (CMPS) September 15, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-08-12
COMPASS Pathways plc (CMPS) August 12, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-05
COMPASS Pathways plc (CMPS) Q2 2026 Earnings Call Transcript
Confident tone Treatment Site Infrastructure Commercial Readiness & Launch Planning Phase 3 Data & De-risking
Diluted EPS
$-1.88
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-05-19
COMPASS Pathways plc (CMPS) May 19, 2026 Conference
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-13
COMPASS Pathways plc (CMPS) Q1 2026 Earnings Call Transcript
Confident tone TRD Phase III data and NDA submission REMS and patient safety framework PTSD program expansion
Diluted EPS
$-0.30
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q3
2025-11-04
COMPASS Pathways plc (CMPS) Q3 2025 Earnings Call Transcript
Confident tone FDA regulatory progress and NDA filing SPRAVATO infrastructure and site readiness COMP360 commercial launch readiness
Diluted EPS
$-1.44
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-07-31
COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript
Confident tone FDA engagement and regulatory path Commercial preparation and launch readiness Phase 3 trial results in TRD
Diluted EPS
$-0.41
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
COMPASS Pathways plc (CMPS) Q1 2025 Earnings Call Transcript
Confident tone COMP360 durability / long-term data Treatment-resistant depression unmet need Commercial preparation and strategic collaborations
Diluted EPS
$-0.24
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
COMPASS Pathways plc (CMPS) Q4 2024 Earnings Call Transcript
Confident tone PTSD program DSMB safety review Phase 3 006 trial
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-10-31
COMPASS Pathways plc (CMPS) Q3 2024 Earnings Call Transcript
Cautious tone Commercial preparation and launch readiness Trial complexity and site management COMP005 Phase III timing and delays
Diluted EPS
$-0.56
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-01
COMPASS Pathways plc (CMPS) Q2 2024 Earnings Call Transcript
Positive tone Phase 3 TRD program (005 and 006 trials) Lykos AdCom insights and FDA considerations PTSD and MDD exploratory programs
Diluted EPS
$-0.56
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-08
COMPASS Pathways plc (CMPS) Q1 2024 Earnings Call Transcript
Positive tone Phase II PTSD data Phase III COMP360 TRD trials Safety and tolerability
Diluted EPS
$-0.55
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
COMPASS Pathways plc (CMPS) Q4 2023 Earnings Call Transcript
Positive tone Phase III TRD program Anxiety opportunity PTSD expansion
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-02
COMPASS Pathways plc (CMPS) Q3 2023 Earnings Call Transcript
Diluted EPS
$-0.67
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
COMPASS Pathways plc (CMPS) Q2 2023 Earnings Call Transcript
Diluted EPS
$-620.00
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
COMPASS Pathways plc (CMPS) Q1 2023 Earnings Call Transcript
Diluted EPS
$-0.57
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-28
COMPASS Pathways plc (CMPS) Q4 2022 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-03
COMPASS Pathways plc (CMPS) Q3 2022 Earnings Call Transcript
Diluted EPS
$-0.43
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
COMPASS Pathways plc (CMPS) Q4 2021 Earnings Call Transcript
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–24 of 24 webcasts
Key facts CIK 1816590 CUSIP 20451W101 13F (30d) 44 filings 44 filers Visit website Investor relations